Bresol inhibits phosphodiesterase 4 gene expression and modulates the levels of select mediators of inflammation in human monocytic cells

Journal of Immunotoxicology

Volumn 8, Issue 4, 2011, Pages 315-323

  Sandeep Varma, R ^a   Ashok, G ^a   Vidyashankar, S ^a   Nandakumar, K S ^a   Patki, P S ^a  

^a Himalaya Health Care   (India)

Author keywords

Allergic rhinitis; Asthma; Bresol; Cyclic adenosine monophosphate; Herbal medicine; Human monocytes; Inflammatory cytokines; Phosphodiesterase 4B

Indexed keywords

ANTIINFLAMMATORY AGENT; BRESOL; CYCLIC AMP; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PHOSPHODIESTERASE IV; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN U937; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; LEUKEMIA CELL; PRIORITY JOURNAL;

CELL SURVIVAL; CYCLIC AMP; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 4; CYCLOOXYGENASE 2; FORMAZANS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INFLAMMATION MEDIATORS; MONOCYTES; NITRIC OXIDE; PHOSPHODIESTERASE 4 INHIBITORS; PLANT PREPARATIONS; TETRAZOLIUM SALTS; TUMOR NECROSIS FACTOR-ALPHA; U937 CELLS;

EID: 80455125667     PISSN: 1547691X     EISSN: None     Source Type: Journal    
DOI: 10.3109/1547691X.2011.603389     Document Type: Article

References (32)

1. Abdolkhaleg, D. and Shokooh, D. 2009. Secreted tumor necrosis factor-alpha by human myeloid cells: A valuable parameter for evaluation of endotoxin contamination in vitro. Immunopharmacol Immunotoxicol 31:405-413.
2. Batra, J., Chatterjee, R. and Ghosh, B. 2007. Inducible nitric oxide synthase (iNOS): Role in asthma pathogenesis. Indian J Biochem Biophys 44:303-309.
3. Bielory, L. and Lupoli, K. 1999. Herbal interventions in asthma and allergy. J Asthma 36:1-65.
4. Bissonnette, E. Y., Enciso, J. A. and Befus, A. D. 1995. Inhibition of tumour necrosis factor-a (TNF-a) release from mast cells by the anti-inflammatory drugs, sodium cromoglycate and nedocromil sodium. Clin Exp Immunol 102:78-84.
5. van der Bruggen, T., Nijenhuis, S., van Raaij, E., Verhoef, J. and van Asbeck, B. S. 1999. Lipopolysaccharide-induced tumor necrosis factor alpha production by human monocytes involves the raf-1/ MEK1-MEK2/ERK1-ERK2 pathway. Infect Immun 67:3824-3829.
6. Chatterjee, S., Pal, S., Panna, S., and Kolhapure, S. A. 2004. Evaluation of efficacy and safety of bresol (HK-07) syrup in pediatric allergic rhinitis. Ind. J. Clin. Practice 15:25-36.
7. Das, A. M., Flower, R. J., Hellewell, P. G., Teixeira, M. M. and Perretti, M. 1997. A novel murine model of allergic inflammation to study the effect of dexamethasone on eosinophil recruitment. Br J Pharmacol 121:97-104.
8. Ergun, M. A., Konac, E., Erbas, D. and Ekmekci, A. 2004. Apoptosis and nitric oxide release induced by thalidomide, gossypol and dexamethasone in cultured human chronic myelogenous leukemic K-562 cells. Cell Biol Int 28:237-242.
9. Ethuin, F., Delarche, C., Benslama, S., Gougerot-Pocidalo, M. A., Jacob, L. and Chollet-Martin, S. 2001. Interleukin-12 increases interleukin-8 production and release by human polymorphonuclear neutrophils. J Leukoc Biol 70:439-446.
10. Fredholm, B. B. and Persson, C. G. 1982. Xanthine derivatives as adenosine receptor antagonists. Eur J Pharmacol 81:673-676.
11. Gopumadhavan, S., Rafiq, M., Venketaranganna, M. V., and Mitra, S. K. 2005. Anti histaminic and antianaphylactic activity of Bresol (HK-07), a herbal formulation. Ind. J. Pharmacol. 37:300-303.
12. Guerra, S., Sherrill, D. L., Martinez, F. D. and Barbee, R. A. 2002. Rhinitis as an independent risk factor for adult-onset asthma. J Allergy Clin Immunol 109:419-425.
13. Howell, R. E., Jenkins, L. P., Fielding, L. E. and Grimes, D. 1995. Inhibition of antigen-induced pulmonary eosinophilia and neutrophilia by selective inhibitors of phosphodiesterase types 3 or 4 in Brown Norway rats. Pulm Pharmacol 8:83-89.
14. Jeffery, P. K. and Haahtela, T. 2006. Allergic rhinitis and asthma: Inflammation in a one-airway condition. BMC Pulm Med 6 Suppl 1:S5.
15. Ma, D., Wu, P., Egan, R. W., Billah, M. M. and Wang, P. 1999. Phosphodiesterase 4B gene transcription is activated by lipopolysaccharide and inhibited by interleukin-10 in human monocytes. Mol Pharmacol 55:50-57.
16. MacKenzie, S. J. and Houslay, M. D. 2000. Action of rolipram on specific PDE4 cAMP phosphodiesterase isoforms and on the phosphorylation of cAMP-response-element-binding protein (CREB) and p38 mitogen-activated protein (MAP) kinase in U937 monocytic cells. Biochem J 347:571-578.
17. Méhats, C., Tanguy, G., Dallot, E., Robert, B., Rebourcet, R., Ferré, F. and Leroy, M. J. 1999. Selective up-regulation of phosphodiesterase-4 cyclic adenosine 3',5'-monophosphate (cAMP)-specific phosphodiesterase variants by elevated cAMP content in human myometrial cells in culture. Endocrinology 140:3228-3237.
18. Mitra, S. K., Varma, S. R., Godavarthi, A. and Nandakumar, K. S. 2008. Liv.52 regulates ethanol induced PPAR? and TNFa expression in HepG2 cells. Mol Cell Biochem 315:9-15.
19. Moody, M. D., Van Arsdell, S. W., Murphy, K. P., Orencole, S. F. and Burns, C. 2001. Array-based ELISAs for high-throughput analysis of human cytokines. BioTechniques 31:186-90, 192.
20. Olsen, P. C., Ferreira, T. P., Serra, M. F., Farias-Filho, F. A., Fonseca, B. P., Viola, J. P., Cordeiro, R. S., Silva, P. M., Costa, J. C. and Martins, M. A. 2011. Lidocaine-derivative JMF2-1 prevents ovalbumininduced airway inflammation by regulating the function and survival of T-cells. Clin Exp Allergy 41:250-259.
21. Pandey, M. K., Singh, S. K., and Patki, P. S. 2010. Efficacy and safety of bresol tablets in the management of bronchial asthma. Ind. J. Clin. Practice 20:707-713.
22. Ring, J. 1978. [Cyclic adenosine 3-5 monophosphate (c-AMP) and allergy]. Hautarzt 29:625-631.
23. Santamaria, L. F., Palacios, J. M. and Beleta, J. 1997. Inhibition of eotaxin-mediated human eosinophil activation and migration by the selective cyclic nucleotide phosphodiesterase type 4 inhibitor rolipram. Br J Pharmacol 121:1150-1154.
24. Sariban, E., Imamura, K., Luebbers, R. and Kufe, D. 1988. Transcriptional and posttranscriptional regulation of tumor necrosis factor gene expression in human monocytes. J Clin Invest 81:1506-1510.
25. Schmidt, B. M., Kusma, M., Feuring, M., Timmer, W. E., Neuhäuser, M., Bethke, T., Stuck, B. A., Hörmann, K. and Wehling, M. 2001. The phosphodiesterase 4 inhibitor roflumilast is effective in the treatment of allergic rhinitis. J Allergy Clin Immunol 108: 530-536.
26. Sun, L., Chang, J., Kirchhoff, S. R. and Knowlton, A. A. 2000. Activation of HSF and selective increase in heat-shock proteins by acute dexamethasone treatment. Am J Physiol Heart Circ Physiol 278: H1091-H1097.
27. Szczeklik, A., Nizankowska, E., Bochenek, G., Nagraba, K., Mejza, F. and Swierczynska, M. 2001. Safety of a specific COX-2 inhibitor in aspirin-induced asthma. Clin Exp Allergy 31:219-225.
28. Tong, Z., Dai, H., Chen, B., Abdoh, Z., Guzman, J. and Costabel, U. 2003. Inhibition of cytokine release from alveolar macrophages in pulmonary sarcoidosis by pentoxifylline: Comparison with dexamethasone. Chest 124:1526-1532.
29. Torphy, T. J. and Undem, B. J. 1991. Phosphodiesterase inhibitors: New opportunities for the treatment of asthma. Thorax 46: 512-523.
30. Varma, R. S., Ashok, G., Vidyashankar, S., Patki, P. and Nandakumar, K. S. 2011a. Anti-inflammatory properties of Septilin in lipopolysaccharide- activated monocytes and macrophage. Immunopharmacol Immunotoxicol 33:55-63.
31. Varma, R. S., Ashok, G., Vidyashankar, S., Patki, P. and Nandakumar, K. S. 2011b. Ethanol extract of Justicia gendarussa inhibits lipopolysaccharide- stimulated nitric oxide and matrix metalloproteinase-9 expression in murine macrophage. Pharm Biol 49:648-652.
32. Yadav, A. K., Paul, B. N., Naik, S., Saxena, A. K. and Patel, D. K. 2004. Human hemoglobin shares bioactivities ascribed to human tumor necrosis factor-a. Immunopharmacol Immunotoxicol 26:559-572.